NXUd Stock Overview

Develops and sells software solutions for the healthcare market in Germany, Switzerland, Liechtenstein, the Netherlands, Poland, France, Austria, and internationally. More details

NXUd fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	3/6
Past Performance	4/6
Financial Health	6/6
Dividends	0/6

Rewards

Trading at 18.3% below our estimate of its fair value

Earnings are forecast to grow 17.06% per year

Earnings grew by 14.4% over the past year

Risk Analysis

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

Nexus AG Competitors

EMIS Group

AIM:EMIS

UK£1.2b

Craneware

AIM:CRW

UK£780.9m

Instem

AIM:INS

UK£199.6m

Spire Healthcare Group

LSE:SPI

UK£906.5m

Price History & Performance

Summary of share price highs, lows and changes for Nexus
Historical stock prices
Current Share Price	€68.60
52 Week High	€68.70
52 Week Low	€60.70
Beta	0.87
1 Month Change	0.44%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	3.47%
5 Year Change	104.17%
Change since IPO	461.83%

Recent updates

Shareholder Returns

	NXUd	GB Healthcare Services	GB Market
7D	0%	-6.9%	-1.5%
1Y	n/a	13.3%	3.5%

Return vs Industry: Insufficient data to determine how NXUd performed against the UK Healthcare Services industry.

Return vs Market: Insufficient data to determine how NXUd performed against the UK Market.

Price Volatility

Is NXUd's price volatile compared to industry and market?
NXUd volatility
NXUd Average Weekly Movement	n/a
Healthcare Services Industry Average Movement	5.0%
Market Average Movement	4.9%
10% most volatile stocks in GB Market	10.6%
10% least volatile stocks in GB Market	2.6%

Stable Share Price: NXUd's share price has been volatile over the past 3 months compared to the UK market.

Volatility Over Time: Insufficient data to determine NXUd's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1989	1,980	Ingo Behrendt	www.nexus-ag.de

Nexus AG develops and sells software solutions for the healthcare market in Germany, Switzerland, Liechtenstein, the Netherlands, Poland, France, Austria, and internationally. The company operates through NEXUS / DE; NEXUS / DIS; and NEXUS / ROE segments. It offers hospital information systems and integrated diagnostic modules that cover various functional requirements of hospitals, psychiatric institutions, rehabilitation facilities, and diagnostic centers, as well as nursing homes.

Nexus AG Fundamentals Summary

How do Nexus's earnings and revenue compare to its market cap?
NXUd fundamental statistics
Market cap	€1.19b
Earnings (TTM)	€26.77m
Revenue (TTM)	€265.36m

44.3x

P/E Ratio

4.5x

P/S Ratio

Is NXUd overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NXUd income statement (TTM)
Revenue	€265.36m
Cost of Revenue	€190.38m
Gross Profit	€74.98m
Other Expenses	€48.22m
Earnings	€26.77m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Mar 04, 2025

Earnings per share (EPS)	1.55
Gross Margin	28.26%
Net Profit Margin	10.09%
Debt/Equity Ratio	0%

How did NXUd perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

14%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/19 22:39
End of Day Share Price	2024/12/12 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nexus AG is covered by 13 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Wolfgang Specht	Berenberg
Charlotte Friedrichs	Berenberg
Martin Jungfleisch	BNP Paribas Exane